Department of Surgery and Physiology & Cardiovascular Research Centre, Faculty of Medicine, University of Porto, Portugal.
Pole of Pharmacology and Therapeutics, Institut de Recherche Experimentale et Clinique (IREC), and Clinique Universitaire Saint-Luc, Université catholique de Louvain, Brussels, Belgium.
Eur J Heart Fail. 2018 Feb;20(2):216-227. doi: 10.1002/ejhf.1059. Epub 2017 Nov 16.
As heart failure with preserved ejection fraction (HFpEF) rises to epidemic proportions, major steps in patient management and therapeutic development are badly needed. With the current position paper we seek to update our view on HFpEF as a highly complex systemic syndrome, from risk factors and mechanisms to long-term clinical manifestations. We will revise recent advances in animal model development, experimental set-ups and basic and translational science approaches to HFpEF research, highlighting their drawbacks and advantages. Directions are provided for proper model selection as well as for integrative functional evaluation from the in vivo setting to in vitro cell function testing. Additionally, we address new research challenges that require integration of higher-order inter-organ and inter-cell communication to achieve a full systems biology perspective of HFpEF.
随着射血分数保留型心力衰竭(HFpEF)的流行程度上升到流行的程度,患者管理和治疗开发的主要步骤是非常必要的。通过本立场文件,我们试图更新我们对 HFpEF 的看法,将其视为一种高度复杂的系统性综合征,涵盖从危险因素和机制到长期临床表现等各个方面。我们将回顾 HFpEF 研究中动物模型开发、实验设置以及基础和转化科学方法的最新进展,强调它们的缺点和优点。我们还提供了正确选择模型以及从体内到体外细胞功能测试的整体功能评估的方向。此外,我们还解决了新的研究挑战,这些挑战需要整合更高阶的器官间和细胞间通讯,以实现 HFpEF 的全系统生物学视角。